BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8092005)

  • 1. Cost-effectiveness in the treatment of patients with schizophrenia.
    Goldberg D
    Acta Psychiatr Scand Suppl; 1994; 382():89-92. PubMed ID: 8092005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness studies in the evaluation of mental health services in the community: current knowledge and unsolved problems.
    Goldberg D
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 5():29-34. PubMed ID: 7622831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs and benefits of hospital and day treatment with community care of affective and schizophrenic disorders.
    Wiersma D; Kluiter H; Nienhuis FJ; Rüphan M; Giel R
    Br J Psychiatry Suppl; 1995 Apr; (27):52-9. PubMed ID: 7794594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs and benefits of day treatment with community care for schizophrenic patients.
    Wiersma D; Kluiter H; Nienhuis FJ; Rüphan M; Giel R
    Schizophr Bull; 1991; 17(3):411-9. PubMed ID: 1947866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of effectiveness and cost between two models of care for individuals with schizophrenia living in Taiwan.
    Lin EC; Yin TJ; Kuo BI; Chang WY; Tsai SL
    Arch Psychiatr Nurs; 2001 Dec; 15(6):272-8. PubMed ID: 11735078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring the economic costs of schizophrenia.
    McGuire TG
    Schizophr Bull; 1991; 17(3):375-88. PubMed ID: 1947861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost of schizophrenia.
    Wasylenki DA
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S65-9. PubMed ID: 7874667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Schizophrenic patients' length of stay: mental health care implication and medicoeconomic consequences].
    Capdevielle D; Boulenger JP; Villebrun D; Ritchie K
    Encephale; 2009 Sep; 35(4):394-9. PubMed ID: 19748377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised controlled trial of two models of care for discharged psychiatric patients.
    Tyrer P; Evans K; Gandhi N; Lamont A; Harrison-Read P; Johnson T
    BMJ; 1998 Jan; 316(7125):106-9. PubMed ID: 9462315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating effectiveness and cost of community care for schizophrenic patients.
    Häfner H; an der Heiden W
    Schizophr Bull; 1991; 17(3):441-51. PubMed ID: 1947869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The societal cost of schizophrenia in Sweden.
    Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
    J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The care of patients with chronic schizophrenia: a comparison between two services.
    Gater R; Goldberg D; Jackson G; Jennett N; Lowson K; Ratcliffe J; Saraf T; Warner R
    Psychol Med; 1997 Nov; 27(6):1325-36. PubMed ID: 9403904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Direct costs of acute day hospital care: results from a randomized controlled trial].
    Kallert TW; Schönherr R; Schnippa S; Matthes C; Glöckner M; Schützwohl M
    Psychiatr Prax; 2005 Apr; 32(3):132-41. PubMed ID: 15818529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economics of schizophrenia.
    Williams R; Dickson RA
    Can J Psychiatry; 1995 Sep; 40(7 Suppl 2):S60-7. PubMed ID: 8564919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of day and inpatient psychiatric treatment: results of a randomised controlled trial.
    Creed F; Mbaya P; Lancashire S; Tomenson B; Williams B; Holme S
    BMJ; 1997 May; 314(7091):1381-5. PubMed ID: 9161310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of schizophrenia in a randomized trial of home-based treatment.
    Burns T; Raftery J
    Schizophr Bull; 1991; 17(3):407-10. PubMed ID: 1947865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding results from randomized trials: use of program- and client-level data to study medical and nonmedical treatment programs.
    Kaskutas LA; Ammon L; Witbrodt J; Graves K; Zemore S; Borkman T; Weisner S
    J Stud Alcohol; 2005 Sep; 66(5):682-7. PubMed ID: 16331853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changed treatment of schizophrenic syndromes. More open care is not cheaper].
    Carlsson P; Holmberg H; Persson R
    Lakartidningen; 1995 May; 92(21):2203-6, 2209. PubMed ID: 7776758
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.